scholarly journals Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Diabetes Care ◽  
2017 ◽  
Vol 41 (2) ◽  
pp. 258-266 ◽  
Author(s):  
Andrew J. Ahmann ◽  
Matthew Capehorn ◽  
Guillaume Charpentier ◽  
Francesco Dotta ◽  
Elena Henkel ◽  
...  
2021 ◽  
Author(s):  
R. Ravi Shankar ◽  
Philip Zeitler ◽  
Asma Deeb ◽  
Muhammad Yazid Jalaludin ◽  
Raymundo Garcia ◽  
...  

2015 ◽  
Vol 8 (5) ◽  
pp. 647-656 ◽  
Author(s):  
Mani Mirfeizi ◽  
Zahra Mehdizadeh Tourzani ◽  
Seyedeh Zahra Mirfeizi ◽  
Mohammad Asghari Jafarabadi ◽  
Hamid Reza Rezvani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document